ReviewEuropean journal of nuclear medicine and molecular imaging2004

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours.

Lisa Bodei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.